nRichDX, Shaun Sanders, Investor Relations Advisor

An emerging leader in the liquid biopsy sample prep market, delivering to downstream molecular testing up to 75X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems.
Speakers
Shaun Sanders
Shaun Sanders
Investor Relations Advisor, nRichDX